HEALTHLEAD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.2 THB | -1.75% |
|
-2.61% | +7.69% |
| Apr. 17 | Healthlead Public Company Limited Approves Dividend for the Year Ended December 31, 2023, Payable on 10 May 2024 | CI |
| Feb. 29 | Healthlead Public Company Limited Announces Management Changes | CI |
| Sales 2024 * | 1.84B 49.53M | Sales 2025 * | 2.2B 59.25M | Capitalization | 3.05B 82.23M |
|---|---|---|---|---|---|
| Net income 2024 * | 84M 2.27M | Net income 2025 * | 101M 2.73M | EV / Sales 2024 * | 1.45 x |
| Net cash position 2024 * | 388M 10.47M | Net cash position 2025 * | 308M 8.31M | EV / Sales 2025 * | 1.25 x |
| P/E ratio 2024 * |
36.1
x | P/E ratio 2025 * |
30.3
x | Employees | - |
| Yield 2024 * |
1.07% | Yield 2025 * |
1.34% | Free-Float | 24.37% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.75% | ||
| 1 week | -2.61% | ||
| Current month | -6.67% | ||
| 1 month | -8.94% | ||
| 3 months | +7.69% | ||
| 6 months | +3.70% | ||
| Current year | +7.69% |
1 week
11.00
11.90
1 month
11.0012.60
Current year
10.0012.60
1 year
9.2019.60
3 years
9.2032.00
5 years
9.2032.00
10 years
9.2032.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 46 | 18-11-30 | |
Araya Tantanasin
DFI | Director of Finance/CFO | 54 | 18-12-31 |
| President | 66 | 18-11-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 18-11-30 | |
| Director/Board Member | 55 | 20-03-31 | |
| Director/Board Member | 50 | 20-03-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 11.2 | -1.75% | 67,501 |
| 24-04-23 | 11.4 | +0.88% | 94,953 |
| 24-04-22 | 11.3 | +1.80% | 173,700 |
| 24-04-19 | 11.1 | -4.31% | 241,606 |
| 24-04-18 | 11.6 | +0.87% | 107,000 |
End-of-day quote Thailand S.E., April 23, 2024
More quotes
Healthlead Public Company Limited is a Thailand-based holding company. The principal businesses of the Company and its subsidiaries include pharmacy business distributing medicines, medical supplies, cosmeceuticals, supplements, medical devices, and other healthcare products as well as in business regarding invention business, developing, importing, and distributing healthcare products. It operates pharmacies under four brands namely Icare, Pharmax, vitaminclub, and Super Drug. The Company sells more than 10,000 stock-keeping units (SKUs) of medical supplies, cosmeceuticals, dietary supplements, medical equipment, and healthcare products via these pharmacies in response to customersâ various needs. Its pharmacies feature medicines, dietary supplements, medical equipment, household utensils, external healthcare products, and consumer goods. Its PRIME brand is a dietary supplement product, which includes PRIME Hibiki Collagen Pure and PRIME Acerola Cherry Extract 1200 MG.
Sector
Drug Retailers
Calendar
2024-05-13
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
11.2
THB
Average target price
12
THB
Spread / Average Target
+7.14%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +7.69% | 83.94M | |
| -31.79% | 15.57B | |
| -36.19% | 9.81B | |
| +9.74% | 6.08B | |
| -10.69% | 6.03B | |
| -35.14% | 5.52B | |
| -0.73% | 4.75B | |
| +52.93% | 4.23B | |
| -11.96% | 3.6B | |
| -6.41% | 3.16B |
- Stock Market
- Equities
- HL Stock
